137 related articles for article (PubMed ID: 9396188)
1. Molecular genetics of renal cell carcinoma.
Vignoli GC; Martorana G
Arch Ital Urol Androl; 1997 Sep; 69(4):265-9. PubMed ID: 9396188
[TBL] [Abstract][Full Text] [Related]
2. [Heredity in renal and prostatic neoplasia].
Prayer Galetti T; D'Arrigo L; De Zorzi L; Patarnello T
Arch Ital Urol Androl; 1997 Sep; 69(4):241-6. PubMed ID: 9417296
[TBL] [Abstract][Full Text] [Related]
3. Evolving classification of renal cell neoplasia.
Delahunt B; Velickovic M; Grebe SK
Expert Rev Anticancer Ther; 2001 Dec; 1(4):576-84. PubMed ID: 12113090
[TBL] [Abstract][Full Text] [Related]
4. Precancerous lesions in the kidney.
Van Poppel H; Nilsson S; Algaba F; Bergerheim U; Dal Cin P; Fleming S; Hellsten S; Kirkali Z; Klotz L; Lindblad P; Ljungberg B; Mulders P; Roskams T; Ross RK; Walker C; Wersäll P
Scand J Urol Nephrol Suppl; 2000; (205):136-65. PubMed ID: 11144893
[TBL] [Abstract][Full Text] [Related]
5. Molecular genetic studies of sporadic and familial renal cell carcinoma.
Gnarra JR; Glenn GM; Latif F; Anglard P; Lerman MI; Zbar B; Linehan WM
Urol Clin North Am; 1993 May; 20(2):207-16. PubMed ID: 8098558
[TBL] [Abstract][Full Text] [Related]
6. Histopathological, cytogenetic, and molecular characterization of renal cortical tumors.
Presti JC; Rao PH; Chen Q; Reuter VE; Li FP; Fair WR; Jhanwar SC
Cancer Res; 1991 Mar; 51(5):1544-52. PubMed ID: 1671759
[TBL] [Abstract][Full Text] [Related]
7. Nonpapillary and papillary renal cell carcinoma: a cytogenetic and phenotypic study.
Hughson MD; Johnson LD; Silva FG; Kovacs G
Mod Pathol; 1993 Jul; 6(4):449-56. PubMed ID: 8415591
[TBL] [Abstract][Full Text] [Related]
8. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
[TBL] [Abstract][Full Text] [Related]
9. Allelic deletions in renal tumors: histopathological correlations.
Presti JC; Reuter VE; Cordon-Cardo C; Mazumdar M; Fair WR; Jhanwar SC
Cancer Res; 1993 Dec; 53(23):5780-3. PubMed ID: 8242636
[TBL] [Abstract][Full Text] [Related]
10. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
[TBL] [Abstract][Full Text] [Related]
11. Differentiation between papillary and nonpapillary renal cell carcinomas by DNA analysis.
Kovacs G; Wilkens L; Papp T; de Riese W
J Natl Cancer Inst; 1989 Apr; 81(7):527-30. PubMed ID: 2921777
[TBL] [Abstract][Full Text] [Related]
12. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.
Zigeuner R; Ratschek M; Rehak P; Schips L; Langner C
Urology; 2004 Apr; 63(4):651-5. PubMed ID: 15072872
[TBL] [Abstract][Full Text] [Related]
13. Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma.
Morris MR; Gentle D; Abdulrahman M; Maina EN; Gupta K; Banks RE; Wiesener MS; Kishida T; Yao M; Teh B; Latif F; Maher ER
Cancer Res; 2005 Jun; 65(11):4598-606. PubMed ID: 15930277
[TBL] [Abstract][Full Text] [Related]
14. Renal cell carcinoma. Molecular genetics and clinical implications.
Jennings SB; Gnarra JR; Walther MM; Zbar B; Linehan WM
Surg Oncol Clin N Am; 1995 Apr; 4(2):219-29. PubMed ID: 7796282
[TBL] [Abstract][Full Text] [Related]
15. The evolving classification of renal cell neoplasia.
Delahunt B; Srigley JR
Semin Diagn Pathol; 2015 Mar; 32(2):90-102. PubMed ID: 25753529
[TBL] [Abstract][Full Text] [Related]
16. Detection of DNA copy number changes and oncogenic signaling abnormalities from gene expression data reveals MYC activation in high-grade papillary renal cell carcinoma.
Furge KA; Chen J; Koeman J; Swiatek P; Dykema K; Lucin K; Kahnoski R; Yang XJ; Teh BT
Cancer Res; 2007 Apr; 67(7):3171-6. PubMed ID: 17409424
[TBL] [Abstract][Full Text] [Related]
17. Next-generation RNA Sequencing-based Biomarker Characterization of Chromophobe Renal Cell Carcinoma and Related Oncocytic Neoplasms.
Skala SL; Wang X; Zhang Y; Mannan R; Wang L; Narayanan SP; Vats P; Su F; Chen J; Cao X; Siddiqui J; Argani P; Cieślik MP; Giordano TJ; Chinnaiyan AM; Dhanasekaran SM; Mehra R
Eur Urol; 2020 Jul; 78(1):63-74. PubMed ID: 32299640
[TBL] [Abstract][Full Text] [Related]
18. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.
Clifford SC; Walsh S; Hewson K; Green EK; Brinke A; Green PM; Gianelli F; Eng C; Maher ER
Genes Chromosomes Cancer; 1999 Sep; 26(1):20-8. PubMed ID: 10441001
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic analysis of epithelial renal-cell tumors: relationship with a new histopathological classification.
van den Berg E; van der Hout AH; Oosterhuis JW; Störkel S; Dijkhuizen T; Dam A; Zweers HM; Mensink HJ; Buys CH; de Jong B
Int J Cancer; 1993 Sep; 55(2):223-7. PubMed ID: 8370620
[TBL] [Abstract][Full Text] [Related]
20. Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease.
Phillips JL; Ghadimi BM; Wangsa D; Padilla-Nash H; Worrell R; Hewitt S; Walther M; Linehan WM; Klausner RD; Ried T
Genes Chromosomes Cancer; 2001 May; 31(1):1-9. PubMed ID: 11284029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
